Rhea, a Singapore-based reproductive health services company, raised follow-on funding of an undisclosed amount.
The round was led by Thiel Capital, with participation from LifeX Ventures, Blue Lion Global, and FJ Labs.
The company intends to use the funds to expand its presence and service offerings in new markets.
Led by CEO Margaret Wang, Rhea is a modern global reproductive health services company elevating fertility journeys for the modern family. Its clinical services are delivered by Rhea’s GenPrime clinic network and a growing number of partner clinics. The company’s clinic network is empowered by Rhea Labs, an integrated technology platform leveraging the flywheel of accelerated time to market and short product feedback loop to improve patient outcomes.
Incubated and developed by Recharge Capital, Rhea serves markets across Asia with additional operations in North America and Europe.
FinSMEs
03/06/2024